Cédric Draulans

ORCID: 0000-0002-1267-7874
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Prostate Cancer Diagnosis and Treatment
  • Prostate Cancer Treatment and Research
  • Advanced Radiotherapy Techniques
  • Radiation Therapy and Dosimetry
  • Bladder and Urothelial Cancer Treatments
  • Occupational and environmental lung diseases
  • Urologic and reproductive health conditions
  • Radiomics and Machine Learning in Medical Imaging
  • Lung Cancer Diagnosis and Treatment
  • Pleural and Pulmonary Diseases
  • Statistical Methods in Clinical Trials
  • Advanced X-ray and CT Imaging
  • Radiopharmaceutical Chemistry and Applications
  • Colorectal Cancer Surgical Treatments
  • Colorectal and Anal Carcinomas
  • Cancer Genomics and Diagnostics
  • Cardiac Arrhythmias and Treatments
  • Management of metastatic bone disease
  • Endometrial and Cervical Cancer Treatments
  • Peripheral Artery Disease Management
  • Olfactory and Sensory Function Studies
  • Effects of Radiation Exposure
  • Migraine and Headache Studies
  • Economic and Financial Impacts of Cancer
  • Colorectal Cancer Screening and Detection

Universitair Ziekenhuis Leuven
2025

KU Leuven
2016-2024

Franco-British Council
2023

San Raffaele University of Rome
2019

University Medical Center Freiburg
2016

Institut de Cancérologie de Lorraine
2016

This study investigates whether focal boosting of the macroscopic visible tumor with external beam radiotherapy increases biochemical disease-free survival (bDFS) in patients localized prostate cancer.In phase III, multicenter, randomized controlled Focal Lesion Ablative Microboost Prostate Cancer trial, 571 intermediate- and high-risk cancer were enrolled between 2009 2015. Patients assigned to standard treatment received 77 Gy (fractions 2.2 Gy) entire prostate. The boost arm an additional...

10.1200/jco.20.02873 article EN Journal of Clinical Oncology 2021-01-20

Purpose or objectivesThe FLAME trial (NCT01168479) showed that by adding a focal boost to conventional fractionated EBRT in the treatment of localized prostate cancer, five-year biochemical disease-free survival increased, without significantly increasing toxicity. The aim present study was investigate association between radiation dose bladder and urethra genitourinary (GU) toxicity grade ≥2 entire cohort.Material methodsThe dose–effect relations dose, separately, GU (CTCAE 3.0) up five...

10.1016/j.radonc.2021.12.027 article EN cc-by Radiotherapy and Oncology 2021-12-28

Background Migraine is much more common in females than males, and occurrence associated with changes female sex hormones. Calcitonin gene-related peptide (CGRP) plays a key role migraine, variations hormones may affect CGRP sensitivity and/or production. Objectives Investigate repeatability, gender differences, influence of the menstrual cycle migraine on CGRP-dependent dermal blood flow (DBF). Methods increases DBF were assessed using laser Doppler perfusion imaging after topical...

10.1177/0333102416668659 article EN Cephalalgia 2016-09-28

Abstract Introduction Stereotactic arrhythmia radioablation (STAR) has emerged as a novel treatment option for patients with ventricular tachycardia (VT) who are either refractory to or have contraindications standard therapies. Purpose To evaluate the efficacy of STAR in VT. Methods The CREVET study is single-centre, prospective investigating safety and treating Eligible participants aged ≥18 years structural heart disease experienced ICD therapy monomorphic VT adding escalating...

10.1093/europace/euaf085.774 article EN cc-by-nc EP Europace 2025-05-01

Purpose Liquid fiducial markers have shown to be a promising alternative solid gold in terms of imaging artifact reduction, patient comfort, and compatibility with different modalities. This study aims investigate the performance novel BioXmark ® liquid marker for state‐of‐the‐art multimodal used prostate cancer ( PC a) radiotherapy, encompassing kV CT / CBCT , multiparametric MRI x‐ray imaging. In addition, automatic detection motion monitoring during treatment was investigated. Methods A...

10.1002/mp.12860 article EN Medical Physics 2018-03-15

In patients with prostate cancer (PCa) histopathologically proven pelvic lymph node (LN) metastasis (pN1) after extended dissection (ePLND), multimodality treatment consisting of the primary tumor and whole radiotherapy (WPRT) combined androgen deprivation therapy (ADT) offers promising results, leading to better cause-specific survival rates compared ADT alone. However, in case more than one LN is invaded by tumor, approximately 40% relapse biochemically clinically. Clinical present...

10.2196/11256 article EN cc-by JMIR Research Protocols 2018-08-02

The integration of auto-segmentation and automated treatment planning methods on a fast-rotating O-ring linac may improve the time efficiency online adaptive radiotherapy workflows. This study investigates whether prostate SBRT with focal boosting could generate plans that are similar quality as those obtained through manual clinical C-arm linacs.

10.1002/acm2.13345 article EN Journal of Applied Clinical Medical Physics 2021-07-28

We sought to expand current prediction tools for lymph node invasion in patients with prostate cancer using state-of-the-art available tumor information, including multiparametric magnetic resonance imaging based stage and detailed biopsy information.We selected study who had registered information on ISUP (International Society of Urological Pathology) grading imaging, undergone radical prostatectomy extended pelvic dissection. developed a tool 420 externally validated it 187. A concordance...

10.1097/ju.0000000000000652 article EN The Journal of Urology 2019-11-13
Coming Soon ...